Evidence map›Paper›PMID 26848749›Full record

ArticlePloS one2016

Comparison of Metabolites Variation and Antiobesity Effects of Fermented versus Nonfermented Mixtures of Cudrania tricuspidata, Lonicera caerulea, and Soybean According to Fermentation In Vitro and In Vivo.

Dong Ho Suh, Eun Sung Jung, Hye Min Park, Seung Hyung Kim, Sarah Lee, Yang Hee Jo, Mi Kyeong Lee, Gayoung Jung, Seon-Gil Do, Choong Hwan Lee

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Controlled Fermentation Using AutochthonousAntibiotics (Basel, Switzerland) · 2020
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Dong Ho SuhDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
Eun Sung JungDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
Hye Min ParkDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
Seung Hyung KimInstitute of Traditional Medicine & Bioscience, Daejeon University, Daejon, Republic of Korea.
Sarah LeeNational Institute of Biological Resources, Incheon, Republic of Korea.
Yang Hee JoCollege of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea.
Mi Kyeong LeeCollege of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea.
Gayoung JungWellness R & D Center, Univera, Inc., Seoul, Republic of Korea.
Seon-Gil DoWellness R & D Center, Univera, Inc., Seoul, Republic of Korea.
Choong Hwan LeeDepartment of Bioscience and Biotechnology, Konkuk University, Seoul, Republic of Korea.
Konkuk University · KRChungbuk National University · KRDaejeon University · KRNational Institute of Biological Resources · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used ultra-performance-liquid-chromatography with quadrupole-time-of-flight mass spectrometry to study the changes in metabolites in the mixture of Cudrania tricuspidata, Lonicera caerulea, and soybean (CLM) during fermentation. Additionally, the antiobesity effects of CLM and fermented-CLM (FCLM) were studied based on the analysis of plasma from high-fat diet (HFD)-fed mice. The levels of cyanidin and the glycosides of luteolin, quercetin, and cyanidin derived from L. caerulea were decreased, whereas the levels of luteolin and quercetin were increased during fermentation. Isoflavone glycosides and soyasaponins originating from the soybean were decreased, whereas their aglycones such as daidzein, glycitein, and genistein were increased. As for prenylated flavonoids from C. tricuspidata, these metabolites were decreased at the early stage of fermentation, and were increased at end of the fermentation. In terms of the functional food product, various metabolites derived from diverse natural products in CLM had complementary effects and demonstrated higher antioxidant and pancreatic lipase inhibition activities after fermentation; these activities were closely related to flavonoid aglycones including genistein, daidzein, glycitein, luteolin, and quercetin. In an in vivo experiment, several clinical parameters affected by HFD were improved by the administration of either CLM or FCLM, but there was a difference in the antiobesity effects. The levels of lysoPCs with C20:4, C16:0, and C22:6 were significantly attenuated by CLM administration, while the attenuated levels of lysoPCs with C20:4 and C18:2 were significantly restored by FCLM administration. These metabolites may explain the above-mentioned differences in antiobesity effects. Although only the changes in plasma lysophospholipids could not fully explain antiobesity effects between non-fermented and fermented plant mixtures from our results, we suggest that metabolomics approach could provide a way to reveal the metabolite alterations in the complex fermentation process and understand the differences or changes in bioactivity according to fermentation.

Indexed as

Anti-Obesity AgentsIsoflavonesAnimalsDietary FatsGlycine maxLoniceraMaleMiceMoraceaeObesityAnti-Obesity AgentsDietary FatsIsoflavones

Identifiers

PMID26848749
PMCPMC4743955
OpenAlexW2253508774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.